Q1 2025 PB Fintech Ltd Earnings Call Transcript
Key Points
- PB Fintech Ltd (BOM:543390) reported a 78% year-on-year growth in new premium for its health and life insurance business for Q1 FY2024-25.
- Total insurance premium for the quarter was INR4,871 crores, with new core insurance premiums growing at 66%.
- Revenue for the quarter grew 52% year-on-year to just over INR1,000 crores, and PAT improved to a profit of INR60 crores.
- Renewal/trail revenue is at an ARR of INR559 crores, up from INR418 crores last year, operating at about 85% margin.
- PB Partners, the agent aggregation platform, continues to lead the market in scale and efficiency, covering over 95% of the country.
- The company overspent by about $3 million this quarter in terms of actual operating capacity.
- Credit-linked revenue was INR130 crores, below expectations and showing a negative growth of about 8% year-on-year.
- The contribution margin has been impacted by the growth in health fresh business, which comes at zero contribution in the first year.
- There was a one-off GST cost of INR25 crores, impacting other expenses.
- The renewal ARR showed a sequential dip this quarter, attributed to the slow growth 12 months ago.
A very warm welcome to PB Fintech Limited earnings call Q1 financial year 2024, 2025.
Today, we have with us, Mr. Yashish Dahiya, Chairman and CEO, PB Fintech; Mr. Alok Bansal, Executive Vice Chairman, PB Fintech; Mr. Sarbvir Singh, Joint Group CEO, PB Fintech; Mr. Naveen Kukreja, Co-Founder and CEO, Paisabazaar; Mr. Mandeep Mehta, Group CFO, PB Fintech; and I'm Rasleen.
I hand over the call to Yashish for the initial address.
Thank you very much, Rasleen. As you were taking all our names, I was in a jovial mood today. So I was just thinking, obviously, it's the same people. Nothing has changed. It's obviously the same Yashish, same Sarbvir, same Mandeep, same Naveen and same Alok.
But yes, I think it wasn't that funny. But anyway, so today we share our performance update for the quarter ended June 30, 2024. We are extremely thrilled with our health and life insurance business, which are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
